Press releases
Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results
25 Mar 24
Earnings, Press Releases
Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
22 Mar 24
News, Press Releases
Nimbus Therapeutics Appoints Katharine Knobil, M.D., to Board of Directors
12 Mar 24
Press Releases
Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for "Neldaleucel" as Nonproprietary Name for MT-601
22 Jan 24
Health Care, Press Releases, General
Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization
8 Jan 24
Press Releases, General